Regeneron Pharmaceuticals (REGN) Shares Issued (2009 - 2026)

Regeneron Pharmaceuticals has reported Shares Issued for 18 years, with the latest figure at $163.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 169.14% year-over-year to $163.1 million; the trailing twelve-month figure through Mar 2026 stood at $738.4 million (down 12.49% YoY), and the FY2025 full-year result was $635.9 million, down 56.6% from the prior year.
• Shares Issued for Q1 2026 stood at $163.1 million, down from $503.5 million in the prior quarter.
• The five-year high for Shares Issued was $682.1 million in Q1 2024, with the low at $31.5 million in Q2 2025.
• Average Shares Issued over 5 years is $290.0 million, with a median of $301.0 million recorded in 2023.
• Peak annual rise in Shares Issued reached 453.91% in 2025, while the deepest fall reached 92.8% in 2025.
• Tracing REGN's Shares Issued over 5 years: stood at $372.6 million in 2022, then retreated by 19.22% to $301.0 million in 2023, then sank by 69.8% to $90.9 million in 2024, then soared by 453.91% to $503.5 million in 2025, then sank by 67.61% to $163.1 million in 2026.
• The last three Shares Issued figures came in at $163.1 million (Q1 2026), $503.5 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.

Peer Comparison